Podcast 19 Jun 2014: A thrilling Dauphine, Belkin's blues, and whaddup with WADA - a podcast by SBS

If the Critérium du Dauphiné is an experiment for the Tour, then July will be a roaring success.

But with so much more to lose, will we see B1 and B2 - that being bravado and bravura - play like they did at the Dauphiné?

It's up for debate by Al Hinds, Anthony Tan and RIDE Cycling Review’s Rob Arnold in this week's Cycling Central podcast.

The trio gauge the form of the GC riders, potential chinks in Sky's armour, and Dauphiné winner Andrew Talansky overtaking Tejay van Garderen as American cycling's Next Big Thing.

What to make of Belkin's premature exit from cycling?

The old adage 'If it ain't broke, don't fix it' surely does not apply to professional cycling - the system is completely broken!

Is cycling a good investment, or do you still need two million to make a million from the sport?

And what ado about TUEs, or Therapeutic Use Exemptions?

Defending Tour champ Chris Froome hurryingly applied for one just prior to the Tour de Romandie, before winning said event.

Given the culture of suspicion still within cycling, shouldn't TUEs be applied for and approved/disapproved prior to the start of each season, and subsequent to that, if you do fall ill, you either man up or take the bench?

Further episodes of Cycling Central Podcast

Further podcasts by SBS

Website of SBS